Teva Can’t Stop Buying

With six acquisitions already on the books in 2015, Teva Pharmaceutical Industries (NYSE: TEVA) announced it would pay $2.3 billion for Representaciones e Investigaciones Médicas (Rimsa), a leading pharmaceutical manufacturing and distribution company in Mexico. Also associated with this deal is a portfolio of products and companies, intellectual property, assets and pharmaceutical patents in Latin America and Europe. With this acquisition, Teva becomes one of the top pharmaceutical companies in Mexico, which is the second largest market in Latin America and one of the top five emerging markets globally. The company expects the deal will yield substantial and achievable synergies and offer... Read More »

Medtronic Acquires Lazarus Effect

You have to admit, naming a company Lazarus Effect sets up some big expectations. Medtronic plc (NYSE: MDT) had that in mind, no doubt, when it paid $100 million for medical device maker Lazarus Effect in late September. The target’s lead product is the Lazarus Cover™, which complements Medtronic’s Solitaire™ stent retriever platform. The technology is designed to address clinical needs with a novel nitinol “mesh cover” that folds over a stent retriever device during clot retrieval and wraps the stent with the clot inside. Medtronic will report the Lazarus Effect product line as part of its Neurovascular division within the Restorative Therapies Group. Read More »

5 Biggest Health Care Deals in Sept. 2015

September 2015 wasn’t a bad month for health care M&A, ever with all the uncertainty shaking the equity markets and surrounding the Fed’s decision to prolong the suspense over raising interest rates. At this moment, spending on the 114 deals we’ve captured in our database is $24.5 billion. Here are the top five deals that made that happen. Next week, third quarter results. AcquirerTargetPrice Dentsply International Inc. Sirona Dental Systems $13.3 billion Concordia Health Care Corp.Amdipharm Mercury Ltd.$3.3 billion Lannett Company, Inc. Kremers Urban Pharmaceuticals$1.2 billion Griffin-American Healthcare REIT IIITrilogy Health Services$1.1 billion BayBridge Seniors Housing Amica... Read More »